Ottobock stock: Ottobock improves adjusted EBITDA margin 3.60 points for Ottobock stock

Published on 10/16/2026 at 17:29 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Core revenue rose 11.70 percent in fiscal year 2025. Ottobock stock costs EUR 53.75 on October 16, 2026, plus 0.09 percent versus the Xetra close.

Operating progress and price

Ottobock reported a 3.60-point increase in its adjusted earnings margin for fiscal year 2025.
Core revenue increased 11.70 percent to EUR 210.0 million in fiscal year 2025.
Ottobock stock costs EUR 53.75 at Lang & Schwarz on October 16, 2026 at 5:13 p.m. CEST, 0.09 percent above the Xetra close of October 15, 2026.
Ottobock operates with 9,300 full-time employees across 45 countries.

Ottobock, DE000BCK2223, Illustration mit AI erstellt.

Ottobock improved its adjusted earnings margin by 3.60 percentage points in fiscal year 2025, while core revenue increased 11.70 percent to EUR 210.0 million, according to Ottobock. The stock was trading at EUR 53.75 at Lang & Schwarz on October 16, 2026 at 5:13 p.m. CEST, 0.09 percent above the Xetra close of October 15, 2026 at EUR 53.70.

Revenue and margin provide the anchor

The fiscal year 2025 figures give the price report an operating benchmark. Core revenue reached EUR 210.0 million, up 11.70 percent from the prior fiscal year, while adjusted earnings before interest, taxes, depreciation and amortization rose to EUR 55.17 million, an increase of 29.50 percent, according to Ottobock.

The adjusted margin stood at 3.46 percent in fiscal year 2025, compared with an increase of 3.60 percentage points stated on the investor page. Adjusted group profit reached EUR 23.50 million, up 83.20 percent over the same period, according to Ottobock.

What does the operating base mean?

The company combines the margin improvement with a broad operating footprint. Ottobock states that it employs almost 9,300 full-time workers, operates in 45 countries and runs more than 430 patient care centers worldwide, according to Ottobock.

For the share price, the small 0.09 percent premium over the Xetra close points to a stable late-session indication rather than a decisive daily move. The relevant comparison is the Xetra close, not the previous Lang & Schwarz figure.

Price holds near the Xetra close

The EUR 53.75 quote at Lang & Schwarz was 0.09 percent above the EUR 53.70 Xetra close of October 15, 2026. At 5:13 p.m. CEST, the quote was in the after-close phase for Xetra trading.

Ottobock is a medical technology company focused on prosthetics, neuro-orthotics and exoskeletons. Its investor page also cites more than 2,600 patents and patent applications, giving the operating profile a measurable innovation component.

The further course of trading is shown by the continuously updated real-time quote of Ottobock stock.